Search Results for "Clinical Trial Influenza Conference 2012"
Original Source: Influenza Congress USA
Innovation and opportunity for Pharma, Biotech, Healthcare and Investors
Matching Channels
ATX-MS-1467 for patients with multiple sclerosis (MS)
ATX-MS-1467 is a novel treatment that was developed with the aim of working with the immune system to treat the underlying cause of disease rather than just treating the symptoms or suppressing the...
BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is an internet agent for Visiongain's life science, medical devices and pharmaceutical conference.
Matching News
First influenza vaccine brought to clinical testing
Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial wi...
Inovio Initiates H1N1 Universal Influenza Vaccine Clinical Trial Targeting Over-65 Population, ...
Clinical Study of SynCon® Influenza Vaccine Alone and With Seasonal H1N1 Vaccine Will Measure Universal Antibody Responses and T-Cell Responses, Which May be Vital to Fighting Influenza in Elderly
A*STAR, Cytos Biotechnology provide update on Phase 1 clinical trial of H1N1 influenza vaccine
Singapore's Agency for Science, Technology and Research and Switzerland's Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their...
Three NIH-sponsored clinical trials test influenza treatments
Three clinical trials that seek to find more effective treatments for influenza are enrolling volunteers with influenza at the National Institutes of Health’s Clinical Center in Bethesda, Md., and a...
Three Clinical Trials Test Influenza Treatments
Three clinical trials that seek to find more effective treatments for influenza are enrolling volunteers with influenza at the National Institutes of Health's Clinical Center in Bethesda, Md., and at...
Conference organizer ExL Pharma is proud to bring the Trial Design In Clinical Drug Development Conference to the Loew's Hotel in Philadelphia, PA on November 15-16, 2012. The mission is to bring to...
Three NIH-sponsored influenza trials begin to enroll volunteers
Three clinical trials that seek to find more effective treatments for influenza are enrolling volunteers with influenza at the National Institutes of Health's Clinical Center in Bethesda, Md., and at...
Sarepta Reaches Clinical Trial Deal For Further Development Of Influenza Drug
WASHINGTON (dpa-AFX) - Sarepta Therapeutics Inc. (SRPT) announced that it has entered into a Clinical Trial Agreement or CTA with the National Institute of Allergy and Infectious Diseases or NIAID...
Matching PubMed Articles
During the 2011-12 influenza season in the United States, influenza activity* occurred at low levels during October through December and increased in January and February before peaking in mid-March....
The burden of influenza disease is to a large extent unknown for the African continent. Moreover, the interaction of influenza with common infectious diseases in Africa remains poorly described. Solid...
Update: influenza activity - United States, september 30, 2012-february 9, 2013.
Influenza activity in the United States began to increase in mid-November and remained elevated through February 9, 2013. During that time, influenza A (H3N2) viruses predominated overall, followed by...
Update: influenza activity - United States and worldwide, may 20-september 22, 2012.
During May 20-September 22, 2012, the United States experienced low levels of seasonal influenza activity overall; however, more seasonal influenza viruses were detected than in the summer months of p...
Update: influenza activity - United States, october 2, 2011-february 11, 2012.
This report summarizes U.S. influenza activity* since the beginning of the 2011-12 influenza season (October 2, 2011) and updates the previous report. From October through early January, influenza act...